Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Clinical Evaluation of Non-Invasive Vagus Nerve Stimulation for Temper Outbursts in People With PWS

ClinicalTrials.gov ID: NCT06144645

Public ClinicalTrials.gov record NCT06144645. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 7:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Dose-Ranging Evaluation of Transcutaneous Vagus Nerve Stimulation (tVNS) to Reduce Temper Outbursts in People With Prader-Willi Syndrome (PWS)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of the VNS4PWS clinical study is to test the efficacy, safety, and acceptability of transcutaneous vagus nerve stimulation (tVNS) treatment in people with PWS.

Study identification

NCT ID
NCT06144645
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Enrollment
102 participants

Conditions and interventions

Eligibility (public fields only)

Age range
10 Years to 40 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 8, 2024 (Actual)
Primary completion
Apr 1, 2027 (Estimated)
Completion
Apr 1, 2027 (Estimated)
Last update posted
Apr 6, 2026

2024 – 2027

United States locations

U.S. sites
18
U.S. states
13
U.S. cities
17
Facility City State ZIP Site status
Stanford University Palo Alto California 94304 —
Rady Children's Hospital San Diego San Diego California 92123 —
Children's Hospital Colorado Aurora Colorado 80045 —
Emory University Atlanta Georgia 30322 —
Rare Disease Research Atlanta Georgia 30329 —
University of Iowa Iowa City Iowa 52242 —
Johns Hopkins Hospital Baltimore Maryland 21205 —
University of Minnesota Minneapolis Minnesota 55454 —
Children's Mercy Kansas City Kansas City Missouri 64108 —
Maimonides Medical Center Brooklyn New York 11219 —
NYU Langone Health Garden City New York 11530 —
Montefiore Medical Center and Albert Einstein College of Medicine The Bronx New York 10461 —
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 —
Nationwide Children's Hospital Columbus Ohio 43205 —
Vanderbilt University Medical Center Nashville Tennessee 37203 —
Christus Children'S San Antonio Texas 78207 —
University of Utah Salt Lake City Utah 84108 —
University of Virginia Charlottesville Virginia 22908 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06144645, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 6, 2026 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06144645 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →